Assessment of SkinVision application to detect skin cancer
Research type
Research Study
Full title
Assessment of SkinVision application to detect skin cancer
IRAS ID
344225
Contact name
Alexa Shipman
Contact email
Sponsor organisation
Portsmouth Hospitals University NHS Trust
Duration of Study in the UK
1 years, 1 months, 31 days
Research summary
In this study, we are evaluating the SkinVision® app, a smartphone application that uses artificial intelligence to triage skin lesions as benign or malignant. The app aims to help users determine if their skin lesions require medical attention, potentially reducing unnecessary doctor visits.
The rising number of skin cancer cases and increasing demands on healthcare services necessitate efficient screening tools. By validating the SkinVision® app, we aim to determine its safety and effectiveness as a screening tool, enabling patients to assess their skin health at home and decide if they need to see a GP.
Participants will have their skin lesions assessed using the SkinVision® app during dermatology visits. The app's results will be compared with those of dermatologists. This study involves no extra visits, just a slightly longer appointment to accommodate the app's use.
We expect to collect data on the app's accuracy in diagnosing various skin lesions. By comparing the app's interpretation of lesions with our dermatologists' opinion, we aim to measure its sensitivity and specificity.
If proven reliable, the SkinVision® app could become a recommended tool for preliminary skin lesion assessment, helping the public by reducing unnecessary doctor visits, saving time, and potentially catching serious issues earlier. It offers the convenience of checking skin health anytime, anywhere.
REC name
London - West London & GTAC Research Ethics Committee
REC reference
24/PR/1260
Date of REC Opinion
1 Nov 2024
REC opinion
Further Information Favourable Opinion